The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery

Advances in Protein Chemistry and Structural Biology

Volumn 96, Issue , 2014, Pages 1-37

  Medina Franco, José L ^a   Méndez Lucio, Oscar ^b   Martinez Mayorga, Karina ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOINFORMATICS; CHEMOMETRICS; COMPUTER MODEL; DRUG DEVELOPMENT; GENERATOR; INFORMATION SCIENCE; MOLECULAR MODEL; PHARMACOPHORE; PROTEIN INTERACTION; PROTEIN LIGAND INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; DRUG DESIGN; HUMAN; METABOLISM; PROCEDURES;

PROTEIN;

ANIMALS; COMPUTER SIMULATION; DRUG DESIGN; DRUG DISCOVERY; HUMANS; INFORMATICS; MODELS, MOLECULAR; PROTEIN INTERACTION MAPS; PROTEINS; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84913581995     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2014.06.001     Document Type: Chapter

References (116)

1. L.B. Akella, and D. DeCaprio Cheminformatics approaches to analyze diversity in compound screening libraries Current Opinion in Chemical Biology 14 2010 325 330
2. Y. Al-Abed, C.N. Metz, K.F. Cheng, B. Aljabari, S. VanPatten, and S. Blau Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity Proceedings of the National Academy of Sciences of the United States of America 108 2011 8224 8227
3. J. Bajorath A perspective on computational chemogenomics Molecular Informatics 32 2013 1025 1028
4. T.E. Balius, S. Mukherjee, and R.C. Rizzo Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons Journal of Computational Chemistry 32 2011 2273 2289
5. P.J. Ballester, A. Schreyer, and T.L. Blundell Does a more precise chemical description of protein-ligand complexes lead to more accurate prediction of binding affinity? Journal of Chemical Information and Modeling 54 2014 944 955
6. M. Baroni, G. Cruciani, S. Sciabola, F. Perruccio, and J.S. Mason A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application Journal of Chemical Information and Modeling 47 2007 279 294
7. M. Bello, M. Martinez-Archundia, and J. Correa-Basurto Automated docking for novel drug discovery Expert Opinion on Drug Discovery 8 2013 821 834
8. R.J. Bienstock Computational drug design targeting protein-protein interactions Current Pharmaceutical Design 18 2012 1240 1254
9. S. Bohanec, and J. Zupan Structure generation of constitutional isomers from structural fragments Journal of Chemical Information and Computer Sciences 31 1991 531 540
10. S.C. Brewerton The use of protein-ligand interaction fingerprints in docking Current Opinion in Drug Discovery & Development 11 2008 356 364
11. C. Bryant, I.D. Kerr, M. Debnath, K.K.H. Ang, J. Ratnam, and R.S. Ferreira Novel non-peptidic vinylsulfones targeting the s2 and s3 subsites of parasite cysteine proteases Bioorganic & Medicinal Chemistry Letters 19 2009 6218 6221
12. D.-S. Cao, Y.-Z. Liang, J. Yan, G.-S. Tan, Q.-S. Xu, and S. Liu PyDPI: Freely available python package for chemoinformatics, bioinformatics, and chemogenomics studies Journal of Chemical Information and Modeling 53 2013 3086 3096
13. F. Cheng, W. Li, Z. Wu, X. Wang, C. Zhang, and J. Li Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space Journal of Chemical Information and Modeling 53 2013 753 762
14. F.X. Cheng, C. Liu, J. Jiang, W.Q. Lu, W.H. Li, and G.X. Liu Prediction of drug-target interactions and drug repositioning via network-based inference PLoS Computational Biology 8 2012 e1002503
15. Y. Cho, J.J. Vermeire, J.S. Merkel, L. Leng, X. Du, and R. Bucala Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors Chemistry & Biology 18 2011 1089 1101
16. V. Chupakhin, G. Marcou, I. Baskin, A. Varnek, and D. Rognan Predicting ligand binding modes from neural networks trained on protein-ligand interaction fingerprints Journal of Chemical Information and Modeling 53 2013 763 772
17. A.M. Clark, and P. Labute 2D depiction of protein-ligand complexes Journal of Chemical Information and Modeling 47 2007 1933 1944
18. P.A. Clemons, N.E. Bodycombe, H.A. Carrinski, J.A. Wilson, A.F. Shamji, and B.K. Wagner Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles Proceedings of the National Academy of Sciences of the United States of America 107 2010 18787 18792
19. P.A. Clemons, J.A. Wilson, V. Dancik, S. Muller, H.A. Carrinski, and B.K. Wagner Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections Proceedings of the National Academy of Sciences of the United States of America 108 2011 6817 6822
20. Z. Cournia, L. Leng, S. Gandavadi, X. Du, R. Bucala, and W.L. Jorgensen Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening Journal of Medicinal Chemistry 52 2009 416 424
21. G.V. Crichlow, K.F. Cheng, D. Dabideen, M. Ochani, B. Aljabari, and V.A. Pavlov Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor The Journal of Biological Chemistry 282 2007 23089 23095
22. M. Cruz-Monteagudo, J.L. Medina-Franco, Y. Pérez-Castillo, O. Nicolotti, M.N.D.S. Cordeiro, and F. Borges Activity cliffs in drug discovery: Dr. Jekyll or Mr. Hyde? Drug Discovery Today 2014 10.1016/j.drudis.2014.02.003
23. Z. Deng, C. Chuaqui, and J. Singh Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions Journal of Medicinal Chemistry 47 2004 337 344
24. Z. Deng, C. Chuaqui, and J. Singh Knowledge-based design of target-focused libraries using protein-ligand interaction constraints Journal of Medicinal Chemistry 49 2006 490 500
25. J. Desaphy, E. Raimbaud, P. Ducrot, and D. Rognan Encoding protein-ligand interaction patterns in fingerprints and graphs Journal of Chemical Information and Modeling 53 2013 623 637
26. H. Dhruv, J.C. Loftus, P. Narang, J.L. Petit, M. Fameree, and J. Burton Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis The Journal of Biological Chemistry 288 2013 32261 32276
27. D. Digles, and G.F. Ecker Self-organizing maps for in silico screening and data visualization Molecular Informatics 30 2011 838 846
28. D. Dimova, Y. Hu, and J. Bajorath Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity Journal of Medicinal Chemistry 55 2012 10220 10228
29. J. Durrant, and J.A. McCammon Molecular dynamics simulations and drug discovery BMC Biology 9 2011 71
30. F. Falchi, F. Caporuscio, and M. Recanatini Structure-based design of small-molecule protein-protein interaction modulators: The story so far Future Medicinal Chemistry 6 2014 343 357
31. M. Fernandez, S. Ahmad, and A. Sarai Proteochemometric recognition of stable kinase inhibition complexes using topological autocorrelation and support vector machines Journal of Chemical Information and Modeling 50 2010 1179 1188
32. P.C. Fricker, M. Gastreich, and M. Rarey Automated drawing of structural molecular formulas under constraints Journal of Chemical Information and Computer Sciences 44 2004 1065 1078
33. J. Garcia-Garcia, J. Bonet, E. Guney, O. Fornes, J. Planas, and B. Oliva Networks of protein-protein interactions: From uncertainty to molecular details Molecular Informatics 31 2012 342 362
34. Glide, v. (2012). Glide. New York: Schrödinger, LLC.
35. J.Y. Gu, H. Zhang, L.R. Chen, S. Xu, G. Yuan, and X.J. Xu Drug-target network and polypharmacology studies of a traditional Chinese medicine for type II diabetes mellitus Computational Biology and Chemistry 35 2011 293 297
36. R. Guha Exploring structure-activity data using the landscape paradigm Wiley Interdisciplinary Reviews: Computational Molecular Science 2 2012 829 841
37. R. Guha, and J.H. Van Drie Assessing how well a modeling protocol captures a structure-activity landscape Journal of Chemical Information and Modeling 48 2008 1716 1728
38. R. Guha, and J.H. Van Drie Structure-activity landscape index: Identifying and quantifying activity cliffs Journal of Chemical Information and Modeling 48 2008 646 658
39. V. Hamon, J.M. Brunel, S. Combes, M.J. Basse, P. Roche, and X. Morelli 2P2Ichem: Focused chemical libraries dedicated to orthosteric modulation of protein-protein interactions Medicinal Chemistry Communications 4 2013 797 809
40. P.M. Holden, W.J. Allen, M. Gochin, and R.C. Rizzo Strategies for lead discovery: Application of footprint similarity targeting HIVgp41 Bioorganic & Medicinal Chemistry 22 2014 651 661
41. Y. Hu, and J. Bajorath Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs Journal of Chemical Information and Modeling 52 2012 670 677
42. Y. Hu, N. Furtmann, M. Gütschow, and J. Bajorath Systematic identification and classification of three-dimensional activity cliffs Journal of Chemical Information and Modeling 52 2012 1490 1498
43. X. Hu, Y. Hu, M. Vogt, D. Stumpfe, and J. Bajorath MMP-cliffs: Systematic identification of activity cliffs on the basis of matched molecular pairs Journal of Chemical Information and Modeling 52 2012 1138 1145
44. M.D. Kelly, and R.L. Mancera Expanded interaction fingerprint method for analyzing ligand binding modes in docking and structure-based drug design Journal of Chemical Information and Computer Sciences 44 2004 1942 1951
45. S. Kim, E.E. Bolton, and S.H. Bryant PubChem3D: Conformer ensemble accuracy Journal of Cheminformatics 5 2013 1
46. D. Kuck, N. Singh, F. Lyko, and J.L. Medina-Franco Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation Bioorganic & Medicinal Chemistry 18 2010 822 829
47. T. Langer Pharmacophores in drug research Molecular Informatics 29 2010 470 475
48. M. Lapins, and J.E.S. Wikberg Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques BMC Bioinformatics 11 2010 339
49. M. Lapins, A. Worachartcheewan, O. Spjuth, V. Georgiev, V. Prachayasittikul, and C. Nantasenamat A unified proteochemometric model for prediction of inhibition of cytochrome P450 isoforms PLoS One 8 2013 e66566
50. +: Multiple ligand-protein interaction diagrams for drug discovery Journal of Chemical Information and Modeling 51 2011 2778 2786
51. S. Li, and B. Zhang Traditional Chinese medicine network pharmacology: Theory, methodology and application Chinese Journal of Natural Medicines 11 2013 110 120
52. F. Lopez-Vallejo, and K. Martinez-Mayorga Furin inhibitors: Importance of the positive formal charge and beyond Bioorganic & Medicinal Chemistry 20 2012 4462 4471
53. Maestro, v. (2012). Maestro. New York: Schrödinger, LLC.
54. G.M. Maggiora On outliers and activity cliffs - Why QSAR often disappoints Journal of Chemical Information and Modeling 46 2006 1535
55. L.R. McLean, Y. Zhang, H. Li, Y.M. Choi, Z.N. Han, and R.J. Vaz Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site Bioorganic & Medicinal Chemistry Letters 20 2010 1821 1824
56. J.L. Medina-Franco Scanning structure-activity relationships with structure-activity similarity and related maps: From consensus activity cliffs to selectivity switches Journal of Chemical Information and Modeling 52 2012 2485 2493
57. J.L. Medina-Franco Activity cliffs: Facts or artifacts? Chemical Biology & Drug Design 81 2013 553 556
58. J.L. Medina-Franco, and R. Aguayo-Ortiz Progress in the visualization and mining of chemical and target spaces Molecular Informatics 32 2013 942 953
59. J.L. Medina-Franco, M.A. Giulianotti, G.S. Welmaker, and R.A. Houghten Shifting from the single to the multitarget paradigm in drug discovery Drug Discovery Today 18 2013 495 501
60. J.L. Medina-Franco, G.M. Maggiora, M.A. Giulianotti, C. Pinilla, and R.A. Houghten A similarity-based data-fusion approach to the visual characterization and comparison of compound databases Chemical Biology & Drug Design 70 2007 393 412
61. J.L. Medina-Franco, K. Martínez-Mayorga, A. Bender, R.M. Marín, M.A. Giulianotti, and C. Pinilla Characterization of activity landscapes using 2D and 3D similarity methods: Consensus activity cliffs Journal of Chemical Information and Modeling 49 2009 477 491
62. J.L. Medina-Franco, K. Martínez-Mayorga, M.A. Giulianotti, R.A. Houghten, and C. Pinilla Visualization of the chemical space in drug discovery Current Computer-Aided Drug Design 4 2008 322 333
63. J.L. Medina-Franco, K. Martinez-Mayorga, and N. Meurice Balancing novelty with confined chemical space in modern drug discovery Expert Opinion on Drug Discovery 9 2014 151 165
64. J.L. Medina-Franco, and J. Yoo Molecular modeling and virtual screening of DNA methyltransferase inhibitors Current Pharmaceutical Design 19 2013 2138 2147
65. O. Mendez-Lucio, J. Perez-Villanueva, R. Castillo, and J.L. Medina-Franco Identifying activity cliff generators of PPAR ligands using SAS maps Molecular Informatics 31 2012 837 846
66. O. Méndez-Lucio, J. Tran, J.L. Medina-Franco, N. Meurice, and M. Muller Towards drug repurposing in epigenetics: Olsalazine as a novel hypomethylating compound active in a cellular context ChemMedChem 9 2014 560 565
67. J. Meslamani, D. Rognan, and E. Kellenberger Sc-PDB: A database for identifying variations and multiplicity of 'druggable' binding sites in proteins Bioinformatics 27 2011 1324 1326
68. Molecular Operating Environment (MOE), version 2013.08. (2013). Montreal, Quebec, Canada: Chemical Computing Group Inc. http://www.chemcomp.com.
69. A. Neugebauer, R.W. Hartmann, and C.D. Klein Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods Journal of Medicinal Chemistry 50 2007 4665 4668
70. D.K. Nevin, D.G. Lloyd, and D. Fayne Rational targeting of peroxisome proliferating activated receptor subtypes Current Medicinal Chemistry 18 2011 5598 5623
71. G. Nicola, T. Liu, and M.K. Gilson Public domain databases for medicinal chemistry Journal of Medicinal Chemistry 55 2012 6987 7002
72. S.I. O'Donoghue, D.S. Goodsell, A.S. Frangakis, F. Jossinet, R.A. Laskowski, and M. Nilges Visualization of macromolecular structures Nature Methods 7 2010 S42 S55
73. J.R. Owen, I.T. Nabney, J.L. Medina-Franco, and F. López-Vallejo Visualization of molecular fingerprints Journal of Chemical Information and Modeling 51 2011 1552 1563
74. G.V. Paolini, R.H.B. Shapland, W.P. van Hoorn, J.S. Mason, and A.L. Hopkins Global mapping of pharmacological space Nature Biotechnology 24 2006 805 815
75. R.S. Pearlman, and K.M. Smith Novel software tools for chemical diversity Perspectives in Drug Discovery and Design 9-11 1998 339 353
76. V.I. Perez-Nueno, O. Rabal, J.I. Borrell, and J. Teixido APIF: A new interaction fingerprint based on atom pairs and its application to virtual screening Journal of Chemical Information and Modeling 49 2009 1245 1260
77. G. Poli, T. Tuccinardi, F. Rizzolio, I. Caligiuri, L. Botta, and C. Granchi Identification of new Fyn kinase inhibitors using a FLAP-based approach Journal of Chemical Information and Modeling 53 2013 2538 2547
78. V. Poongavanam, and J. Kongsted Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition PLoS One 8 2013 e73478
79. P. Prusis, M. Lapins, S. Yahorava, R. Petrovska, P. Niyomrattanakit, and G. Katzenmeier Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases Bioorganic & Medicinal Chemistry 16 2008 9369 9377
80. O. Rabal, and J. Oyarzabal Biologically relevant chemical space navigator: From patent and structure-activity relationship analysis to library acquisition and design Journal of Chemical Information and Modeling 52 2012 3123 3137
81. T.J. Ritchie, P. Ertl, and R. Lewis The graphical representation of ADME-related molecule properties for medicinal chemists Drug Discovery Today 16 2011 65 72
82. D. Rognan Towards the next generation of computational chemogenomics tools Molecular Informatics 32 2013 1029 1034
83. W.H.B. Sauer, and M.K. Schwarz Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity Journal of Chemical Information and Computer Sciences 43 2003 987 1003
84. Schrödinger Suite 2012 Protein Preparation Wizard. Epik version 2.3. (2012). New York: Schrödinger; Impact version 5.8. (2005). New York: Schrödinger, LLC; Prime version 3.1. (2012). New York: Schrödinger, LLC.
85. T. Scior, A. Bender, G. Tresadern, J.L. Medina-Franco, K. Martínez-Mayorga, and T. Langer Recognizing pitfalls in virtual screening: A critical review Journal of Chemical Information and Modeling 52 2012 867 881
86. B. Seebeck, M. Wagener, and M. Rarey From activity cliffs to target-specific scoring models and pharmacophore hypotheses ChemMedChem 6 2011 1630 1639
87. V. Shanmugasundaram, and G.M. Maggiora Characterizing property and activity landscapes using an information-theoretic approach CINF-032 222nd ACS National Meeting, Chicago, IL 2001 American Chemical Society Washington, DC
88. P. Siedlecki, R.G. Boy, T. Musch, B. Brueckner, S. Suhai, and F. Lyko Discovery of two novel, small-molecule inhibitors of DNA methylation Journal of Medicinal Chemistry 49 2006 678 683
89. F. Sirci, E.P. Istyastono, H.F. Vischer, A.J. Kooistra, S. Nijmeijer, and M. Kuijer Virtual fragment screening: Discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints Journal of Chemical Information and Modeling 52 2012 3308 3324
90. K. Stierand, and M. Rarey From modeling to medicinal chemistry: Automatic generation of two-dimensional complex diagrams ChemMedChem 2 2007 853 860
91. K. Stierand, and M. Rarey Drawing the PDB: Protein-ligand complexes in two dimensions ACS Medicinal Chemistry Letters 1 2010 540 545
92. K. Stierand, and M. Rarey Flat and easy: 2D depiction of protein-ligand complexes Molecular Informatics 30 2011 12 19
93. D. Stumpfe, Y. Hu, D. Dimova, and J. Bajorath Recent progress in understanding activity cliffs and their utility in medicinal chemistry Journal of Medicinal Chemistry 57 2014 18 28
94. Y. Tabei, E. Pauwels, V. Stoven, K. Takemoto, and Y. Yamanishi Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers Bioinformatics 28 2012 i487 i494
95. N. Takada, N. Ohmori, and T. Okada Mining basic active structures from a large-scale database Journal of Cheminformatics 5 2013 15
96. L. Tan, J. Batista, and J. Bajorath Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information Chemical Biology & Drug Design 76 2010 191 200
97. N. Uchikoga, and T. Hirokawa Analysis of protein-protein docking decoys using interaction fingerprints: Application to the reconstruction of CaM-ligand complexes BMC Bioinformatics 11 2010 236
98. O.P.J. van Linden, A.J. Kooistra, R. Leurs, L.J.P. de Esch, and C. de Graaf KLIFS: A knowledge-based structural database to navigate kinase-ligand interaction space Journal of Medicinal Chemistry 57 2014 249 277
99. G.J.P. van Westen, A. Hendriks, J.K. Wegner, A.P. Ijzerman, H.W.T. van Vlijmen, and A. Bender Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data PLoS Computational Biology 9 2013 e1002899
100. G.J.P. van Westen, O.O. van den Hoven, R. van der Pijl, T. Mulder-Krieger, H. de Vries, and J.K. Wegner Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data Journal of Medicinal Chemistry 55 2012 7010 7020
101. G.J.P. van Westen, J.K. Wegner, P. Geluykens, L. Kwanten, I. Vereycken, and A. Peeters Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development PLoS One 6 2011 e27518
102. G.J.P. van Westen, J.K. Wegner, A.P. Ijzerman, H.W.T. van Vlijmen, and A. Bender Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets Medicinal Chemistry Communications 2 2011 16 30
103. A.M. Virshup, J. Contreras-García, P. Wipf, W. Yang, and D.N. Beratan Stochastic voyages into uncharted chemical space produce a representative library of all possible drug-like compounds Journal of the American Chemical Society 135 2013 7296 7303
104. I. Vogt, and J. Mestres Drug-target networks Molecular Informatics 29 2010 10 14
105. A.C. Wallace, R.A. Laskowski, and J.M. Thornton Ligplot: A program to generate schematic diagrams of protein-ligand interactions Protein Engineering 8 1995 127 134
106. M. Wawer, E. Lounkine, A.M. Wassermann, and J. Bajorath Data structures and computational tools for the extraction of SAR information from large compound sets Drug Discovery Today 15 2010 630 639
107. M. Weisel, H.-M. Bitter, F. Diederich, W.V. So, and R. Kondru Prolix: Rapid mining of protein-ligand interactions in large crystal structure databases Journal of Chemical Information and Modeling 52 2012 1450 1461
108. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: From orphan receptors to drug discovery Journal of Medicinal Chemistry 43 2000 527 550
109. Y. Yamanishi Inferring chemogenomic features from drug-target interaction networks Molecular Informatics 32 2013 991 999
110. Y. Yamanishi, E. Pauwels, H. Saigo, and V. Stovent Extracting sets of chemical substructures and protein domains governing drug-target interactions Journal of Chemical Information and Modeling 51 2011 1183 1194
111. A. Yongye, K. Byler, R. Santos, K. Martínez-Mayorga, G.M. Maggiora, and J.L. Medina-Franco Consensus models of activity landscapes with multiple chemical, conformer and property representations Journal of Chemical Information and Modeling 51 2011 1259 1270
112. A.B. Yongye, and J.L. Medina-Franco Data mining of protein-binding profiling data identifies structural modifications that distinguish selective and promiscuous compounds Journal of Chemical Information and Modeling 52 2012 2454 2461
113. J. Yoo, J.H. Kim, K.D. Robertson, and J.L. Medina-Franco Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: Discovery of a novel DNMT1 inhibitor Advances in Protein Chemistry and Structural Biology 87 2012 219 247
114. J. Yoo, and J.L. Medina-Franco Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: Insights from enzymatic and molecular modeling studies Journal of Molecular Modeling 18 2012 1583 1589
115. M.Z. Zhao, Q. Zhou, W.H. Ma, and D.Q. Wei Exploring the ligand-protein networks in traditional Chinese medicine: Current databases, methods, and applications Evidence-Based Complementary and Alternative Medicine 2013 2013 article ID 806072, 15 pages
116. G. Zinzalla, and D.E. Thurston Targeting protein-protein interactions for therapeutic intervention: A challenge for the future Future Medicinal Chemistry 1 2009 65 93